Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Teladoc Health, Inc. | 4LL | Nov 22, 2024 | 10.30 | +10.94 |
Tele2 ADR B | NCY | Nov 22, 2024 | 4.78 | 0.00 |
Tele2 B | NCYD | Nov 22, 2024 | 9.84 | +2.22 |
Telecom Argentina SA | TEO | Nov 22, 2024 | 12.70 | +4.10 |
Telecom Italia S.p.A. | TQI1 | Nov 22, 2024 | 2.58 | -0.77 |
Telecom Italia S.p.A. | TQIA | Nov 22, 2024 | 2.22 | -1.77 |
Telecom Italia S.p.A. PRF PERPETUAL EUR 0.55 | TQIR | Nov 22, 2024 | 0.27 | -2.33 |
Telecom Italia SpA/Milano | TQI | Nov 22, 2024 | 0.23 | -1.14 |
Telecom Plus PLC | T8T | Nov 22, 2024 | 20.80 | +0.97 |
Teledyne Technologies Inc | TYZ | Nov 22, 2024 | 461.50 | +1.01 |
Teleflex Incorporated | TBH | Nov 22, 2024 | 180.00 | +2.86 |
Telefonica Brasil S.A. American Depositary Shares (Each repr | TSPA | Nov 22, 2024 | 8.15 | -2.40 |
Telefonica S.A | TNE5 | Nov 22, 2024 | 4.25 | -1.25 |
Telefonica SA | TNE2 | Nov 22, 2024 | 4.20 | -1.41 |
Telekom Austria AG | TA1 | Nov 22, 2024 | 7.70 | -0.13 |
Telenor | TEQ | Nov 22, 2024 | 11.29 | +0.89 |
Teleperformance | RCF | Nov 22, 2024 | 88.68 | +0.41 |
TELEPERFORMANCE SA | RCF0 | Nov 22, 2024 | 43.00 | -0.92 |
Telesat | ZE2 | Nov 22, 2024 | 11.30 | +4.63 |
Teleste | TS6 | Nov 22, 2024 | 2.26 | -2.16 |
Telia Company | TLS | Nov 22, 2024 | 2.68 | -0.45 |
Telia Company AB | TLSG | Nov 22, 2024 | 5.20 | 0.00 |
Telia Lietuva | ZWS | Nov 22, 2024 | 1.53 | -0.97 |
TELIX PHARMACEUTICALS LTD | T3X | Nov 22, 2024 | 13.81 | +2.26 |
Telkom SA SOC Ltd | TZL1 | Nov 22, 2024 | 1.61 | 0.00 |
Tellusgruppen | 7FW | Nov 22, 2024 | 0.59 | -0.84 |
Telo Genomics Corp | 3D0A | Nov 22, 2024 | 0.04 | -28.57 |
TELSTRA GROUP LTD | 5KBA | Nov 22, 2024 | 2.38 | +0.63 |
Telus Corp. | BCZ | Nov 22, 2024 | 14.50 | 0.00 |
TELUS International (Cda) Inc | 5Z9 | Nov 22, 2024 | 3.40 | +3.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.